| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Moleculin Biotech, Inc.
13D
MBRX · 60855D408
|
9.9% |
8/25/2026
Event 8/19/2026
|
||||
| Klemp Walter V | 9.9% | |||||
| AnnaMed, Inc. | 0.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.